Search Results - "Dare, Jason A."
-
1
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
Published in The Journal of clinical investigation (01-07-2018)“…Monogenic IFN-mediated autoinflammatory diseases present in infancy with systemic inflammation, an IFN response gene signature, inflammatory organ damage, and…”
Get full text
Journal Article -
2
A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis
Published in Pediatric rheumatology online journal (26-06-2018)“…Juvenile idiopathic arthritis (JIA) is an inflammatory arthritis of unknown etiology, which lasts for greater than 6 weeks with onset before 16 years of age…”
Get full text
Journal Article -
3
Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry Seven‐Year Interim Results
Published in Arthritis care & research (2010) (01-10-2020)“…Objective To evaluate safety and effectiveness of adalimumab (ADA) in polyarticular‐course juvenile idiopathic arthritis (JIA) in the STRIVE registry. Methods…”
Get full text
Journal Article -
4
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti–Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-03-2019)“…Objective To determine the relationship between serum levels of S100A8/A9 and S100A12 and the maintenance of clinically inactive disease during anti–tumor…”
Get full text
Journal Article -
5
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-09-2018)“…Objective To determine the frequency, time to flare, and predictors of disease flare upon withdrawal of anti–tumor necrosis factor (anti‐TNF) therapy in…”
Get full text
Journal Article -
6
Reintroduction of etanercept during treatment of cutaneous Mycobacterium marinum infection in a patient with ankylosing spondylitis
Published in Arthritis and rheumatism (15-05-2009)“…First page of article…”
Get full text
Journal Article -
7
Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label Study
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-07-2018)“…To investigate the pharmacokinetics, effectiveness, and safety of subcutaneous (SC) abatacept treatment over 24 months in patients with polyarticular-course…”
Get full text
Journal Article -
8
Myositis‐Associated Autoantibodies in Patients With Juvenile Myositis Are Associated With Refractory Disease and Mortality
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-06-2024)“…Objective Myositis‐associated autoantibodies (MAAs) have been associated with overlap myositis, certain disease manifestations such as interstitial lung…”
Get full text
Journal Article -
9
Immunome perturbation is present in patients with juvenile idiopathic arthritis who are in remission and will relapse upon anti-TNFα withdrawal
Published in Annals of the rheumatic diseases (01-12-2019)“…Biologics treatment with antitumour necrosis factor alpha (TNFα) is efficacious in patients with juvenile idiopathic arthritis (JIA). Despite displaying…”
Get more information
Journal Article -
10
Risk, Timing and Predictors of Disease Flare after Discontinuation of Anti-Tumor Necrosis Factor (TNF) Therapy in Children with Polyarticular Forms of Juvenile Idiopathic Arthritis (JIA) in Clinical Inactive Disease
Published in Arthritis & rheumatology (Hoboken, N.J.) (25-07-2018)Get full text
Journal Article -
11
Serum S100A8/A9 and S100A12 Levels in Children with Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinical Inactive Disease During and Flare after Discontinuation of Anti-TNF Therapy
Published in Arthritis & rheumatology (Hoboken, N.J.) (24-01-2019)Get full text
Journal Article -
12
Subcutaneous Abatacept in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-07-2018)“…Objective To investigate the pharmacokinetics, effectiveness, and safety of subcutaneous (SC) abatacept treatment over 24 months in patients with…”
Get full text
Journal Article -
13
Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry 7-Year Interim Results
Published in Arthritis care & research (2010) (17-08-2019)“…To evaluate safety and effectiveness of adalimumab (ADA) in polyarticular-course juvenile idiopathic arthritis (pcJIA) in the STRIVE registry (NCT00783510)…”
Get full text
Journal Article -
14